Loading clinical trials...
Loading clinical trials...
Effect of Caloric Restriction on Metabolic Biomarkers and Fat Oxidation in Obese Men and Women (Magellan II)
Conditions
Interventions
Low Calorie Diet (LCD)
Phentermine
Locations
1
United States
Translational Research Institute for Metabolism and Diabetes
Orlando, Florida, United States
Start Date
September 1, 2011
Primary Completion Date
November 1, 2012
Completion Date
November 1, 2012
Last Updated
November 13, 2020
NCT07472881
NCT01143454
NCT07010757
NCT06989203
NCT06223555
NCT07237750
Lead Sponsor
AdventHealth Translational Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions